Cytokine combinations in immunotherapy for solid tumors: a review Keith M. HeatonElizabeth A. Grimm Review Pages: 213 - 219
Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C Shinya ArinagaNobuya KarimineTsuyoshi Akiyoshi Original Articles Pages: 220 - 226
Interleukin-5 induces tumor suppression by peritoneal exudate cells in mice Yasunari NakashimaSeiji MitaMichio Ogawa Original Articles Pages: 227 - 232
Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumors Avi EisenthalYehuda SkornickSamario Chaitchik Original Articles Pages: 233 - 239
In vitro expansion and analysis of T lymphocyte microcultures obtained from the vaccination sites of cancer patients undergoing active specific immunization with autologous Newcastle-disease-virus-modified tumour cells M. StoeckC. Marland-NoskeV. Schirrmacher Original Articles Pages: 240 - 244
Synergetic effect of interleukin-2 and cellular cytotoxicity against a novel tumor-associated carbohydrate antigen Lea/Lea (dimeric Lea) mediated by monoclonal antibody NCC-ST-421 in adoptive immunization using SCID mice Masahiko WatanabeTetsuro KubotaSen-itiroh Hakomori Original Articles Pages: 245 - 250
Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy Pekka Uotila Original Articles Pages: 251 - 254
Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies Gail D. LewisIrene FigariH. Michael Shepard Original Articles Pages: 255 - 263
Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1) J. FagerbergJ-E. FrödinH. Mellstedt Original Articles Pages: 264 - 270
Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice Joep J. BergersWillem Den OtterDaan J. A. Crommelin Original Articles Pages: 271 - 279
